389
Views
5
CrossRef citations to date
0
Altmetric
Review

Estimating the economic consequences of substance use and substance use disorders

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 869-876 | Received 02 Jan 2021, Accepted 09 Apr 2021, Published online: 26 Apr 2021

References

  • GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258): 1223–1249. .
  • Barrio P, Reynolds J, Garcia-Altes A, et al. Social costs of illegal drugs, alcohol and tobacco in the European Union: a systematic review. Drug Alcohol Rev. 2017;36(5):578–588.
  • Shield KD, Rehm MX, Rehm J. Social costs of addiction in Europe. In: Anderson P, Rehm J, Room R, editors. The impact of addictive substances and behaviours on individual and societal well-being. Oxford, UK: Oxford University Press; 2015. p. 181–188.
  • Canadian Substance Use Costs and Harms Scientific Working Group, Stockwell T, Dorocicz J, Sherk A, et al. Canadian Substance Use Costs and Harms (2015-2017) [report]. Ottawa, Ontario: Canadian Centre on Substance Use and Addiction; 2020. [cited 2020 Dec 28]. Available from: https://www.ccsa.ca/sites/default/files/2020-06/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2020-en.pdf
  • Varney SJ, Guest JF. The annual societal cost of alcohol misuse in Scotland. Pharmacoeconomics. 2002;20(13):891–907.
  • Bommer C, Heesemann E, Sagalova V, et al. The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study. Lancet Diabetes Endocrinol. 2017;5(6):423–430.
  • Rice DP. Estimating the cost of illness. Health Economics Series. Rockville, MD: US Department of Health, Education, and Welfare;; 1966. ( No. 6. DHEW Publication No. (PHS) 947-6).
  • Rice DP. Estimating the cost of illness. Am J Public Helath Nations Health. 1967;57(3):424–440.
  • Byford S, Torgerson DJ, Raftery J. Cost of illness studies. Bmj. 2000;320(7245):1335.
  • Clabaugh G, Ward MM. Cost of illness studies in the United States: a systematic review of methodologies used for direct cost. Value Health. 2008;11(1):13–21.
  • Drummond M. Cost-of-illness studies. Pharmacoeconomics. 1992;2(1):1–4.
  • Hodgson TA, Meiners MR. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Mem Fund Q Health Soc. 1982 Summer;60(3):429–62.
  • Case A, Deaton A. Deaths of Despair and the Future of Capitalism. New Jersey: Princeton University Press; 2020.
  • Mcm DG, Suhrcke M, Toffolutti V, et al. How economic crisis affect alcohol consumption and alcohol-related health problems: a realist systematic review. Soc Sci Med. 2015;131:131–146.
  • Bukhman G, Mocumbi AO, Atun R, et al. The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion. Lancet. 2020;396(10256):991–1044. .
  • Patel V, Chisholm D, Parikh R, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities. Lancet. 2016;387(10028):1672–1685. .
  • Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol. 2014;20(4):327.
  • Single E, Collins D, Easton B, et al. International guidelines for estimating the costs of substance abuse. Report No.: 9241545828. Geneva, Switzerland: WHO; 2003. Available from: https://apps.who.int/iris/handle/10665/42603. Accessed: 14/ 12/2020.
  • Rehm J, Marmet S, Anderson P, et al. Defining substance use disorders: do we really need more than heavy use? Alcohol Alcohol. 2013;48(6):633–640. .
  • Rehm J. How should prevalence of alcohol use disorders be assessed globally? Int J Methods Psychiatr Res. 2016;25(2):79–85.
  • Rehm J, Heilig M. Gual A. ICD-11 for Alcohol Use Disorders: not a Convincing Answer to the Challenges. Alcohol Clin Exp Res. 2019;43(11):2296–2300.
  • Heilig M, MacKillop J, Martinez D, et al. Addiction as a brain disease revised: why it still matters, and the need for consilience. Neuropsychopharmacology. 2020 (in press)
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th edition ed. Philadelphia, USA: American Psychiatric Association;; 2013.
  • World Health Organization. ICD-11 for Mortality and Morbidity Statistics.2018.[cited 2019 Jul 10]. Available from: https://icd.who.int/browse11/l-m/en.
  • Rehm J, Gmel GE Sr., Gmel G, et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction. 2017;112(6):968–1001.
  • Rehm J, Shield K, Gmel G, et al. Modeling the impact of alcohol dependence on mortality burden and the effect of available treatment interventions in the European Union. Eur Neuropsychopharmacol. 2013;23(2):89–97.
  • Rovira P, Rehm J. Estimation of cancers caused by light to moderate alcohol consumption in the European Union. Eur J Public Health. 2020. DOI:https://doi.org/10.1093/eurpub/ckaa236
  • Bagnardi V, Rota M, Botteri E, et al. Light alcohol drinking and cancer: a meta-analysis. Ann Oncol. 2013;24(2):301–308.
  • Mohapatra S, Patra J, Popova S, et al. Social cost of heavy drinking and alcohol dependence in high-income countries. Int J Public Health. 2010;55(3):149–157.
  • Møller L, Matic S. World Health Organization Regional Office for Europe. Best practice in estimating the costs of alcohol: recommendations for future studies. Copenhagen: WHO Regional Office for Europe; 2010.
  • Murray CJ, Lopez AD. On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology. 1999;10(5):594–605.
  • Rehm J, Monteiro M, Room R, et al. Steps towards constructing a global comparative risk analysis for alcohol consumption: determining indicators and empirical weights for patterns of drinking, deciding about theoretical minimum, and dealing with different consequences. Eur Addict Res. 2001;7(3):138–147.
  • Rehm J, Room R, Monteiro M. et al. Alcohol Use. In: Ezzati M, Rodgers ADL,A, Murray CJL. editors. Comparative quantification of health risks; Global and regional burden of disease attributable to selected major risk factors. Geneva: World Health Organization, 2004:959–1108. Vol 1. 1.
  • Rehm J, Gnam W, Popova S, et al. The costs of alcohol, illegal drugs, and tobacco in Canada, 2002. J Stud Alcohol Drugs. 2007;68(6):886–895. .
  • Kj R, Greenland S, Tl L. Modern Epidemiology. 3rd ed ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012.
  • Levin ML. The occurrence of lung cancer in man. Acta Union Int Contra Cancrum. 1953;9(3):531–541.
  • Shield K, Manthey J, Rylett M, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Health. 2020;5(1):e51–e61.
  • Single E, Robson L, Xie X, et al. The economic costs of alcohol, tobacco and illicit drugs in Canada, 1992. Addiction. 1998;93(7):991–1006.
  • Barillo DJ, Goode R. Substance abuse in victims of fire. J Burn Carc Rchabilitation. 1996;17(1):71–76.
  • Carr S, Rehm J, Manthey J. Guidelines and reality in studies on the economic costs of alcohol use: a systematic review. Int J Alcohol Drug Res;2021. DOI:https://doi.org/10.7895/ijadr.283 Online ahead of print Feb 1
  • Rehm J, Mathers C, Popova S, et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet. 2009;373(9682):2223–2233.
  • Thavorncharoensap M, Teerawattananon Y, Yothasamut J, et al. The economic impact of alcohol consumption: a systematic review. Subst Abuse Treat Prev Policy. 2009;4(1):20.
  • Lund IO, Sundin E, Konijnenberg C, et al. Harm to Others From Substance Use and Abuse. Subst Abuse. 2015;9(Suppl 2):119–124.
  • Poznyak V, Reed GM, Medina-Mora ME. Aligning the ICD-11 classification of disorders due to substance use with global service needs. Epidemiol Psychiatr Sci. 2018;27(3):212–218.
  • Doran C, Jainullabudeen T, Room R, et al. How much does alcohol really cost Australian drinkers and others affected by drinking? Sydney: National Drug and Alcohol Research Centre, University of Sydney; 2010.
  • Brouwer WB, Koopmanschap MA. The friction-cost method. Pharmacoeconomics. 2005;23(2):105–111.
  • Carvalho AF, Heilig M, Perez A, et al. Alcohol use disorders. Lancet. 2019;394(10200):781–792.
  • Pastor D, Glova J, Lipták F, et al. Intangibles and methods for their valuation in financial terms: literature review. Intangible Capital. 2017;13(2):387.
  • Jeanrenaud C, Pellegrini S. Valuing intangible costs of alcohol dependence: a contingent valuation study. Revue d’économie politique. 2007;117(5):813–825.
  • Le Gall-Ely M. Definition, measurement and determinants of the consumer’s willingness to pay: a critical synthesis and avenues for further research. Recherche Et Applications En Marketing (English Edition). 2009;24(2):91–112.
  • Manthey J, Hassan SA, Carr S, et al. What are the economic costs to society attributable to alcohol use? A systematic review and modelling study. PharmacoEconomics.
  • Crosland P, Ananthapavan J, Davison J, et al. The economic cost of preventable disease in Australia: a systematic review of estimates and methods. Aust N Z J Public Health. 2019;43(5):484–495.
  • Cartwright WS. Economic costs of drug abuse: financial, cost of illness, and services. J Subst Abuse Treat. 2008;34(2):224–233.
  • Makate M, Whetton S, Tait RJ, et al. Tobacco cost of illness studies: a systematic review. Nicotine Tobacco Res. 2020;22(4):458–465. .
  • World Health Organization Regional Office for Europe. Factsheet - Sustainable Development Goals: health targets. Alcohol consumption and sustainable development. Copenhagen: World Health Organization; 2020. [cited 2021 Jan 02]. Available from: https://www.euro.who.int/__data/assets/pdf_file/0008/464642/Alcohol-consumption-and-sustainable-development-factsheet-eng.pdf
  • Heineken. Homepage (beer and brewing website). Amsterdam: Heineken; 2021. [cited 2021 Jan 02]. Available from: https://www.theheinekencompany.com/age-gate/566
  • Willits-Smith A, Aranda R, Heller MC, et al. Addressing the carbon footprint, healthfulness, and costs of self-selected diets in the USA: a population-based cross-sectional study. Lancet Planet Health. 2020;4(3):e98–e106.
  • Hartunian NS, Smart CN, Thompson MS. The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis. Am J Public Health. 1980;70(12):1249–1260.
  • Chisholm D, Doran C, Shibuya K, et al. Comparative cost-effectiveness of policy instruments for reducing the global burden of alcohol, tobacco and illicit drug use. Drug Alcohol Rev. 2006;25(6):553–565.
  • Chisholm D, Moro D, Bertram M, et al. Are the “Best Buys” for Alcohol Control Still Valid? An Update on the Comparative Cost-Effectiveness of Alcohol Control Strategies at the Global Level. J Stud Alcohol Drugs. 2018;79(4):514–522. .
  • Mäkelä K. Cost-of-alcohol studies as a research programme. Nord Stud Alcohol Drugs. 2012;29(4):321–343.
  • Stenius K. Why should we discuss cost-of-alcohol studies? Kerstin Stenius. Nord Stud Alcohol Drugs. 2012;29(4):319–320.
  • Bhattacharya A. Which cost of alcohol? What should we compare it against? Addiction. 2017;112(4):559–565.
  • Bhattacharya A. The political salience of the cost of alcohol should make it a research priority. Addiction. 2017;112(4):571.
  • Canadian Substance Use Costs and Harms Scientific Working Group. Canadian Substance Use Costs and Harms(2007-2014) .2018. [cited 2020 Dec 17]. Available from: http://www.ccsa.ca/Resource%20Library/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2018-en.pdf.
  • Bardach AE, Alcaraz AO, Ciapponi A, et al. Alcohol consumption’s attributable disease burden and cost-effectiveness of targeted public health interventions: a systematic review of mathematical models. BMC Public Health. 2019;19(1):1378. .
  • Sherk A, Stockwell T, Rehm J, et al. The International Model of Alcohol Harms and Policies: a New Method for Estimating Alcohol Health Harms With Application to Alcohol-Attributable Mortality in Canada. J Stud Alcohol Drugs. 2020;81(3):339–351.
  • Rehm J, Taylor B, Patra J, et al. Avoidable burden of disease: conceptual and methodological issues in substance abuse epidemiology. Int J Methods Psychiatr Res. 2006;15(4):191.
  • Vella VA, García-Altes A, Segura García L, et al. Systematic review of guidelines in estimating social costs on drugs. Gac Sanit. 2019;32(5):481–487.
  • Warner KE. An endgame for tobacco? Tob Control. 2013 May;22 Suppl 1(Suppl 1):i3-5. DOI: https://doi.org/10.1136/tobaccocontrol-2013-050989. PMID: 23591502; PMCID: PMC3632965.
  • Rehm J, Casswell S, Manthey J, et al. Reducing the Harmful Use of Alcohol: have International Targets Been Met? Eur J Risk Regul. 2020:1–12 Epubahead of print Oct 8. https://doi.org/10.1017/err.2020.84
  • Manthey J, Shield KD, Rylett M, et al. Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study. Lancet. 2019;393(10190):2493–2502.
  • Anderson P, Gual A, Rehm J. Reducing the health risks derived from exposure to addictive substances. Curr Opin Psychiatry. 2018;31(4):333–341.
  • Blocker JS Jr. Did prohibition really work? Alcohol prohibition as a public health innovation. Am J Public Health. 2006;96(2):233–243.
  • Štelemėkas M, Manthey J, Badaras R, et al. Alcohol control policy measures and all-cause mortality in Lithuania: an interrupted time-series analysis. Addiction. 2021. DOI:https://doi.org/10.1111/add.15470. (in press).
  • Rehm J, Patra J, Popova S. Alcohol drinking cessation and its effect on esophageal and head and neck cancers: a pooled analysis. Int J Cancer. 2007;121(5):1132–1137.
  • Collins D, Lapsley H, Brochu S, et al. International guidelines for the estimation of the avoidable costs of substance abuse. Ottawa: Health Canada; 2006.
  • Bennett JE, Kontis V, Mathers CD, et al. NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4. Lancet. 2020;396(10255):918–934. [PMID: 32891217].
  • Patra J, Rehm J, Popova S. Avoidable alcohol-attributable criminality and its costs due to selected interventions in Canada. Int J Drug Policy. 2011;22(2):109–119.
  • Popova S, Patra J, Gnam W, et al. Alcohol-related laws and avoidable burden and its costs due to motor vehicle collisions in Canada. Contemp Drug Probl. 2011;38(3):467–485.
  • Rehm J, Patra J, Gnam WH, et al. Avoidable cost of alcohol abuse in Canada. Eur Addict Res. 2011;17(2):72–79.
  • The Health Officers Council of British Columbia. Public Health Perspectives for Regulating Psychoactive Substances: what We Can Do About Alcohol, Tobacco, and Other Drugs. Vancouver, British Columbia 2011. [cited 2020 Dec 28]. Available from: http://healthofficerscouncil.net/wp-content/uploads/2012/12/regulated-models-v8-final.pdf
  • Rehm J, J-f C, Hasan OS, et al. Regulatory policies for alcohol, other psychoactive substances and addictive behaviours: the role of level of use and potency. Int J Environ Res Public Health. 2019;16(19):3749.
  • Sherk A. At-a-glance-The alcohol deficit: Canadian government revenue and societal costs from alcohol. Health Promotion Chronic Dis Prev Canada. 2020;40(5–6):139.
  • Statistics Canada. Net income of liquor authorities and government revenue from sale of alcoholic beverages (1,000). Ottawa, Canada: Statistics Canada,; 2020. [cited 2020 Aug 12]. Available from: https://www150.statcan.gc.ca/t1/tbl1/en/tv.action?pid=1010001201. Accessed: 12/ 08/2020.
  • Pigou AC. The Economics of Welfare. London: Macmillan; 1920.
  • Sornpaisarn B, Shield KD, Österberg E, et al. Resource tool on alcohol taxation and pricing policies. Geneva, Switzerland: World Health Organization and others; 2017.
  • Jyani G, Prinja S, Ambekar A, et al. Health impact and economic burden of alcohol consumption in India. Int J Drug Policy. 2019;69:34–42.
  • Gururaj G, Gautham MS, Arvind BA. Alcohol consumption in India: a rising burden and a fractured response. In Drug and Alcohol Review. 2021;40(3):368-384. DOI: https://doi.org/10.1111/dar.13179.
  • Vining A, Weimer DL. An assessment of important issues concerning the application of benefit-cost analysis to social policy. J Benefit-Cost Anal. 2010;1(1):1–40.
  • Institute of Alcohol Studies (IAS). Splitting The Bill: alcohol’s Impact On The Economy. London, UK: IAS; 2017. [cited 2020 Dec 28]. Available from: http://www.ias.org.uk/uploads/pdf/IAS%20summary%20briefings/sb15022017.pdf
  • Anderson P, Baumberg B Cost benefit analyses of alcohol policy - a primer. Luxembourg: Executive Agency for Health and Consumers; 2010. [cited 2020 Dec 28]. Available from: http://www.prevencionbasadaenlaevidencia.net/uploads/PDF/ODI_CostBenefitAnalysisAlcoholPolic_Anderson.pdf
  • Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention. Substance Abuse Prevention Dollars and Cents: a Cost-Benefit Analysis Rockville, MD: U.S. Department of Health and Human Services; 2008. [cited 2020 Dec 28]. Available from: https://www.samhsa.gov/sites/default/files/cost-benefits-prevention.pdf.
  • Connolly K, Bhattacharya A, Lisenkova K, et al. Can a policy‐induced reduction in alcohol consumption improve health outcomes and stimulate the UK economy?: a potential ‘double dividend’. Drug Alcohol Rev. 2019;38(5):554–560.
  • Anderson P, Braddick F, Conrod P, et al. The new governance of addictive substances and behaviours. Oxford, U.K.: Oxford University Press; 2017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.